abstract |
The invention relates to benzylamine phosphilipase A 2 inhibitors, pharmaceutical compositions containing them, and methods of treating phospholipase A 2 -mediated conditions in mammals by administration of a therapeutically effective amount of such a benzylamine phospholipase A 2 inhibitor. |